Rate My Professor Jennifer Koplin

Koplin has led major NHMRC-funded population-based cohort studies, including the EarlyNuts study and the age-10 follow-up of the HealthNuts cohort involving over 7,000 participants, to investigate the prevalence, natural history, causes, and consequences of childhood food allergy. She is co-investigator on SchoolNuts, MACS, food allergy prevention RCTs such as VITALITY, PrEggNuts, TrEAT, and Pebbles, and the food allergy treatment RCT LMNOP. Her research program has secured over $20 million in competitive funding as chief investigator, including six NHMRC project grants and two consecutive NHMRC fellowships. She has authored more than 150 peer-reviewed journal articles with over 4,500 citations, including key publications such as "Association between earlier introduction of peanut and prevalence of peanut allergy in infants in Australia" (JAMA, 2022), "Earlier ingestion of peanut after changes to infant feeding guidelines: the EarlyNuts study" (Journal of Allergy and Clinical Immunology, 2019), and "Role of domestic animal exposure" (Encyclopedia of Food Allergy, 2024). Koplin serves on the editorial board of the Journal of Allergy and Clinical Immunology: In Practice and contributed to the development of new Australian and international guidelines on infant feeding for preventing food allergy. Her work focuses on population-based strategies to reduce allergy prevalence.